EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access

Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score

Aaron J Deutsch, Andrew S Bell, Dominika A Michalek, Adam B Burkholder, Stella Nam, Raymond J Kreienkamp, Seth A Sharp, Alicia Huerta-Chagoya, Ravi Mandla, Ruth Nanjala, Yang Luo, Richard A Oram und 8 weitere

Diabetes · 2026

DOI: 10.2337/db25-0772 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Diabetes, 2026. Verfasst von Aaron J Deutsch und 19 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Unit, Endocrine Division, Department of Medicine, Massachusetts General Hospital, Boston, MA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Multifactorial Inheritance, Genetic Risk Score. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Novo Nordisk Foundation, Foundation for the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polygenic scores strongly predict type 1 diabetes risk, but most scores were developed in European-ancestry populations. In this study, we leveraged recent multiancestry genome-wide association studies to create a Type 1 Diabetes Multi-Ancestry Polygenic Score (T1D MAPS). We trained the score in the Mass General Brigham (MGB) Biobank (372 individuals with type 1 diabetes) and tested the score in the All of Us program (86 individuals with type 1 diabetes). We evaluated the area under the receiver operating characteristic curve (AUC), and we compared the AUC to two published single-ancestry scores for European (EUR) and African (AFR) populations: T1D Genetic Risk Score 2 (GRS2EUR) and T1D GRSAFR. We also developed an updated score (T1D MAPS2) that combines T1D GRS2EUR and T1D MAPS. Among individuals with non-European ancestry, the AUC of T1D MAPS was 0.90, significantly higher than T1D GRS2EUR (0.82) and T1D GRSAFR (0.82). Among individuals with European ancestry, the AUC of T1D MAPS was slightly lower than T1D GRS2EUR (0.89 vs. 0.91). However, T1D MAPS2 performed equivalently to T1D GRS2EUR in European ancestry (0.91 vs. 0.91) and performed better in non-European ancestry (0.90 vs. 0.82). Overall, these findings advance the accuracy of type 1 diabetes genetic risk prediction across diverse populations. Article Highlights Type 1 diabetes polygenic scores are highly predictive of disease risk, but their performance varies based on genetic ancestry. Can we develop a polygenic score that accurately predicts type 1 diabetes risk across diverse populations? Our novel polygenic score performs similar to existing scores in European populations, and it demonstrates superior performance in non-European populations. This polygenic score will improve prediction of type 1 diabetes risk in genetically diverse populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Multifactorial InheritanceGenetic Risk ScoreAdultFemaleHumansMaleBlack PeopleGenetic Predisposition to DiseaseGenome-Wide Association StudyPolymorphism, Single NucleotideROC CurveWhite People

Autor:innen und Institutionen

  • Diabetes Unit, Endocrine Division, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA.
  • Programs in Metabolism and Medical & Population Genetics, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
  • Department of Medicine, Harvard Medical School, Boston, MA.
  • Department of Genome Sciences, University of Virginia, Charlottesville, VA.
  • Office of Environmental Science Cyberinfrastructure, National Institute of Environmental Health Sciences, Durham, NC.

ORCID-Profile: Miriam S Udler

Förderung

  • NIDDK NIH HHS
  • Novo Nordisk Foundation
  • Foundation for the National Institutes of Health
  • NHGRI NIH HHS
  • Medical University of Bialystok (MUB)
  • American Diabetes Association
  • Doris Duke Charitable Foundation
  • National Human Genome Research Institute

Zitieren

APA

Deutsch, A. J., Bell, A. S., Michalek, D. A., Burkholder, A. B., Nam, S., Kreienkamp, R. J., Sharp, S. A., Huerta-Chagoya, A., Mandla, R., Nanjala, R., Luo, Y., Oram, R. A., Florez, J. C., Onengut-Gumuscu, S., Rich, S. S., Ng, M. C. Y., Motsinger-Reif, A. A., Manning, A. K., Mercader, J. M., & Udler, M. S. (2026). Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score. Diabetes. https://doi.org/10.2337/db25-0772

Vancouver

Deutsch AJ, Bell AS, Michalek DA, Burkholder AB, Nam S, Kreienkamp RJ, et al. Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score. Diabetes. 2026. doi:10.2337/db25-0772

BibTeX
@article{Deutsch2026,
  author = {Deutsch, Aaron J and Bell, Andrew S and Michalek, Dominika A and Burkholder, Adam B and Nam, Stella and Kreienkamp, Raymond J and Sharp, Seth A and Huerta-Chagoya, Alicia and Mandla, Ravi and Nanjala, Ruth and Luo, Yang and Oram, Richard A and Florez, Jose C and Onengut-Gumuscu, Suna and Rich, Stephen S and Ng, Maggie C Y and Motsinger-Reif, Alison A and Manning, Alisa K and Mercader, Josep M and Udler, Miriam S},
  title = {Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score},
  journal = {Diabetes},
  year = {2026},
  doi = {10.2337/db25-0772}
}
Kostenlos starten →